Home › Asset managers › Guggenheim › 2024-2025 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Guggenheim voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
2,496 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Guggenheim voted | Funds |
|---|---|---|---|---|---|---|---|
| Lucid Diagnostics Inc. | June 18, 2025 | Election of Class A Directors: Stanley N. Lapidus | Director Elections | Board | WITHHOLD | 1 | |
| McKesson Corporation | July 31, 2024 | Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2025 | Audit-related | Board | AGAINST | 1 | |
| McKesson Corporation | July 31, 2024 | Shareholder Proposal on Report on Risks of State Policies Restricting Reproductive Health Care | Other Social Issues | Shareholder | Against | FOR | 1 |
| MiNK Therapeutics, Inc. | June 18, 2025 | To approve the option exchange proposal. | Compensation | Board | AGAINST | 1 | |
| MiNK Therapeutics, Inc. | June 18, 2025 | To elect Jennifer Buell and Ulf Wiinberg as Class I directors, each for a term of three years expiring at the 2028 Annual Meeting of Stockholders: Jennifer Buell | Director Elections | Board | WITHHOLD | 1 | |
| Molecular Templates, Inc. | September 27, 2024 | To elect one director to serve a three-year term expiring in 2027: Corsee Sanders, Ph.D. | Director Elections | Board | AGAINST | 1 | |
| Mustang Bio, Inc. | December 26, 2024 | Election of Directors: David Jin | Director Elections | Board | WITHHOLD | 1 | |
| Mustang Bio, Inc. | December 26, 2024 | Election of Directors: Lindsay A. Rosenwald, M.D. | Director Elections | Board | WITHHOLD | 1 | |
| Mustang Bio, Inc. | December 26, 2024 | Election of Directors: Manuel Litchman, M.D. | Director Elections | Board | WITHHOLD | 1 | |
| Mustang Bio, Inc. | December 26, 2024 | Election of Directors: Michael S. Weiss | Director Elections | Board | WITHHOLD | 1 | |
| NetApp, Inc. | September 11, 2024 | Election of Directors: Gerald Held | Director Elections | Board | AGAINST | 1 | |
| NetApp, Inc. | September 11, 2024 | Election of Directors: T. Michael Nevens | Director Elections | Board | AGAINST | 1 | |
| NetApp, Inc. | September 11, 2024 | To ratify the appointment of Deloitte & Touche LLP as NetApp's independent registered public accounting firm for the fiscal year ending April 25, 2025. | Audit-related | Board | AGAINST | 1 | |
| Office Properties Income Trust | June 12, 2025 | Election of Trustees. Nominees (for Independent Trustee): Elena B. Poptodorova | Director Elections | Board | WITHHOLD | 1 | |
| Office Properties Income Trust | June 12, 2025 | Election of Trustees. Nominees (for Independent Trustee): Jeffrey P. Somers | Director Elections | Board | WITHHOLD | 1 | |
| Office Properties Income Trust | June 12, 2025 | Election of Trustees. Nominees (for Managing Trustee): Adam Portnoy | Director Elections | Board | WITHHOLD | 1 | |
| Ontrak, Inc. | September 10, 2024 | To approve the Company's Amended and Restated 2017 Stock Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Ontrak, Inc. | September 10, 2024 | To approve the Company's non-employee director retention plan. | Compensation | Board | AGAINST | 1 | |
| Ontrak, Inc. | September 10, 2024 | To elect three directors to hold office until the next annual meeting of stockholders and until their respective successors are elected and qualified: Michael E. Sherman | Director Elections | Board | WITHHOLD | 1 | |
| Outset Medical, Inc. | June 2, 2025 | Election of Class II Directors: D. Keith Grossman | Director Elections | Board | WITHHOLD | 1 | |
| Outset Medical, Inc. | June 2, 2025 | Election of Class II Directors: Patrick T. Hackett | Director Elections | Board | WITHHOLD | 1 | |
| Outset Medical, Inc. | June 2, 2025 | To approve an amendment to our 2020 Equity Incentive Plan to increase the number of shares of common stock available for issuance under the plan by 1,950,000 shares | Compensation | Board | AGAINST | 1 | |
| PAVmed Inc. | June 18, 2025 | Approval of an amendment to the Company's 2014 Long-Term Incentive Equity Plan to increase the total number of shares of the Company's common stock available under the 2014 Plan by an additional 2,500,000 shares, to 4,912,140 shares | Compensation | Board | AGAINST | 1 | |
| PAVmed Inc. | June 18, 2025 | Election of Class C Directors: Lishan Aklog, M.D. | Director Elections | Board | WITHHOLD | 1 | |
| PAVmed Inc. | June 18, 2025 | Election of Class C Directors: Michael J. Glennon | Director Elections | Board | WITHHOLD | 1 | |
| PLBY Group, Inc. | June 16, 2025 | Approve an amendment to PLBY Group, Inc.'s Second Amended and Restated Certificate of Incorporation (the "Charter") to Increase PLBY Group, Inc.'s number of authorized shares of common stock from 150,000,000 to 400,000,000. | Capital Structure | Board | AGAINST | 1 | |
| PLBY Group, Inc. | June 16, 2025 | Election of Directors: Juliana F. Hill | Director Elections | Board | WITHHOLD | 1 | |
| PMV Pharmaceuticals, Inc. | June 5, 2025 | Election of Class II Directors: Charles M. Baum, M.D., Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| PT Telkom Indonesia (Persero) Tbk | May 27, 2025 | Approve Changes in the Boards of the Company | Director Elections | Board | AGAINST | 1 | |
| Passage Bio, Inc. | May 28, 2025 | To elect two Class II directors, each to serve a three-year term through the third Annual Meeting of Stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Maxine Gowen, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Personalis, Inc. | May 16, 2025 | Election of Directors: Karin Eastham | Director Elections | Board | WITHHOLD | 1 | |
| Precision BioSciences, Inc. | May 28, 2025 | Election of Class III Directors: Kevin J. Buehler | Director Elections | Board | WITHHOLD | 1 | |
| Precision BioSciences, Inc. | May 28, 2025 | Election of Class III Directors: Shari Lisa Pire | Director Elections | Board | WITHHOLD | 1 | |
| Quince Therapeutics, Inc. | June 4, 2025 | To elect three Class III nominees for directors to hold office until the 2028 annual meeting of stockholders and until their respective successors are elected and qualified: June Bray | Director Elections | Board | WITHHOLD | 1 | |
| RYVYL Inc. | December 19, 2024 | To approve the Company's amendment to the 2023 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Rafael Holdings, Inc. | January 9, 2025 | Election of Directors: Howard S. Jonas | Director Elections | Board | AGAINST | 1 | |
| Rafael Holdings, Inc. | January 9, 2025 | Election of Directors: Michael J. Weiss | Director Elections | Board | AGAINST | 1 | |
| Rafael Holdings, Inc. | January 9, 2025 | Election of Directors: Stephen M. Greenberg | Director Elections | Board | AGAINST | 1 | |
| Rafael Holdings, Inc. | January 9, 2025 | To approve an amendment to the Rafael Holdings, Inc. 2021 Equity Incentive that will increase the number of shares of the Company's Class B common stock available for the grant of awards thereunder by 750,000. | Compensation | Board | AGAINST | 1 | |
| Regis Corporation | November 6, 2024 | Approval of the Amended and Restated 2018 Long Term Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Rithm Property Trust Inc. | June 2, 2025 | Election of Directors: Daniel Hoffman | Director Elections | Board | WITHHOLD | 1 | |
| Rithm Property Trust Inc. | June 2, 2025 | Election of Directors: Mary Haggerty | Director Elections | Board | WITHHOLD | 1 | |
| Scilex Holding Company | June 20, 2025 | Election of Directors: Henry Ji, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Scilex Holding Company | June 20, 2025 | Election of Directors: Jaisim Shah | Director Elections | Board | WITHHOLD | 1 | |
| Seelos Therapeutics, Inc. | November 25, 2024 | To elect two Class II directors, Raj Mehra, Ph.D. and Brian Lian, Ph.D., nominated by our Board of Directors, to serve until our 2027 annual meeting of stockholders or until his successor is duly elected and qualified: Raj Mehra, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Senseonics Holdings, Inc. | May 21, 2025 | Election of directors: Douglas A. Roeder | Director Elections | Board | WITHHOLD | 1 | |
| Senseonics Holdings, Inc. | May 21, 2025 | Election of directors: Douglas S. Prince | Director Elections | Board | WITHHOLD | 1 | |
| Senseonics Holdings, Inc. | May 21, 2025 | Election of directors: Stephen P. DeFalco | Director Elections | Board | WITHHOLD | 1 | |
| Seres Therapeutics, Inc. | April 10, 2025 | Election of Directors: Dennis A. Ausiello | Director Elections | Board | WITHHOLD | 1 | |
| Shinhan Financial Group Co., Ltd. | March 26, 2025 | Elect Bae Hun as Outside Director | Director Elections | Board | AGAINST | 1 | |
| Shinhan Financial Group Co., Ltd. | March 26, 2025 | Elect Bae Hun as a Member of Audit Committee | Director Elections | Board | AGAINST | 1 | |
| Shinhan Financial Group Co., Ltd. | March 26, 2025 | Elect Gwak Su-geun as Outside Director to Serve as an Audit Committee Member | Director Elections | Board | AGAINST | 1 | |
| Shinhan Financial Group Co., Ltd. | March 26, 2025 | Elect Jeong Sang-hyeok as Non-Independent Non-Executive Director | Director Elections | Board | AGAINST | 1 | |
| Shinhan Financial Group Co., Ltd. | March 26, 2025 | Elect Kim Jo-seol as Outside Director | Director Elections | Board | AGAINST | 1 | |
| Shinhan Financial Group Co., Ltd. | March 26, 2025 | Elect Lee Yong-guk as Outside Director | Director Elections | Board | AGAINST | 1 | |
| Shinhan Financial Group Co., Ltd. | March 26, 2025 | Elect Lee Yong-guk as a Member of Audit Committee | Director Elections | Board | AGAINST | 1 | |
| Shinhan Financial Group Co., Ltd. | March 26, 2025 | Elect Yoon Jae-won as Outside Director | Director Elections | Board | AGAINST | 1 | |
| Shinhan Financial Group Co., Ltd. | March 26, 2025 | Elect Yoon Jae-won as a Member of Audit Committee | Director Elections | Board | AGAINST | 1 | |
| Spero Therapeutics, Inc. | June 12, 2025 | To approve an amendment to the Company's 2017 Stock Incentive Plan, as amended, to increase the total number of shares of common stock authorized for issuance thereunder by 3,000,000 shares. | Compensation | Board | AGAINST | 1 | |
| Suzano SA | April 25, 2025 | Elect Luiz Augusto Marques Paes as Fiscal Council Member and Luciano Douglas Colauto as Alternate | Compensation | Board | ABSTAIN | 1 | |
| Suzano SA | April 25, 2025 | Elect Rubens Barletta as Fiscal Council Member and Roberto Figueiredo Mello as Alternate | Compensation | Board | ABSTAIN | 1 | |
| Talis Biomedical Corporation | November 12, 2024 | Approve Plan of Dissolution | Extraordinary Transactions | Board | AGAINST | 1 | |
| Tectonic Therapeutic, Inc. | June 6, 2025 | Election of Directors: Alise Reicin, M.D. | Director Elections | Board | WITHHOLD | 1 | |
| Tectonic Therapeutic, Inc. | June 6, 2025 | Election of Directors: Praveen Tipirneni, M.D. | Director Elections | Board | WITHHOLD | 1 | |
| Telesis Bio Inc. | June 23, 2025 | Approve Omnibus Stock Plan | Compensation | Board | AGAINST | 1 | |
| Tencent Music Entertainment Group | June 27, 2025 | Elect Director Wai Yip Tsang | Director Elections | Board | AGAINST | 1 | |
| The Cato Corporation | May 22, 2025 | ELECTION OF DIRECTORS: D. Harding Stowe | Director Elections | Board | WITHHOLD | 1 | |
| The Children's Place, Inc. | May 7, 2025 | Election of Directors: Muhammad Asif Seemab | Director Elections | Board | AGAINST | 1 | |
| The Children's Place, Inc. | May 7, 2025 | Election of Directors: Muhammad Umair | Director Elections | Board | AGAINST | 1 | |
| The Children's Place, Inc. | May 7, 2025 | Election of Directors: Turki Saleh A. AlRajhi | Director Elections | Board | AGAINST | 1 | |
| Vaxart, Inc. | June 13, 2025 | Election of Directors: David Wheadon, M.D. | Director Elections | Board | WITHHOLD | 1 | |
| Vaxart, Inc. | June 13, 2025 | Election of Directors: Elaine J. Heron, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Vaxart, Inc. | June 13, 2025 | Election of Directors: W. Mark Watson | Director Elections | Board | WITHHOLD | 1 | |
| Veritone, Inc. | June 13, 2025 | Approve an amendment and restatement of the 2023 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Veritone, Inc. | June 13, 2025 | Election of Directors: Knute P. Kurtz | Director Elections | Board | WITHHOLD | 1 | |
| Veritone, Inc. | June 13, 2025 | Election of Directors: Michael Zilis | Director Elections | Board | WITHHOLD | 1 | |
| Vincerx Pharma, Inc. | August 12, 2024 | Approval of a one-time stock option repricing and exchange program. | Compensation | Board | AGAINST | 1 | |
| Vor Biopharma Inc. | May 22, 2025 | To elect each of the two Class I director nominees, each to serve until the 2028 annual meeting of stockholders and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation or removal: Matthew Patterson | Director Elections | Board | WITHHOLD | 1 | |
| Vuzix Corporation | June 17, 2025 | To approve, the grant of 594,056 restricted stock units (or RSUs) to executive officers and other employees of the Company under the Company's 2023 Equity Incentive Plan, including 291,878 RSUs to Paul Travers, the Company's chief executive officer, and 118,211 RSUs to Grant Russell, the Company's chief financial officer along with the cancellation of 5,089,500 unvested stock options originally granted to those Senior Officers and others on March 17, 2021. | Compensation | Board | AGAINST | 1 | |
| Wipro Limited | July 18, 2024 | Approve Wipro Limited Employee Stock Options, Performance Stock Unit and/or Restricted Stock Unit Scheme 2024 for Grant of Employee Stock Options, Performance Stock Units and/or Restricted Stock Units to Eligible Employees under 2024 Scheme | Compensation | Board | AGAINST | 1 | |
| Wipro Limited | April 1, 2025 | Approve Extension of Benefits under the ADS Restricted Stock Unit Plan 2004 to the Eligible Employees of Wipro Limited Group Companies, Including its Subsidiaries and Associate Companies | Compensation | Board | AGAINST | 1 | |
| Wipro Limited | April 1, 2025 | Approve Migration of Shares Allocated for the Restricted Stock Units under the Wipro Employee Restricted Stock Unit Plan 2005 and Wipro Employee Restricted Stock Unit Plan 2007 to the ADS Restricted Stock Unit Plan 2004 | Compensation | Board | AGAINST | 1 | |
| Woori Financial Group, Inc. | March 26, 2025 | Elect Yoon In-seop as Outside Director | Director Elections | Board | AGAINST | 1 | |
| XPeng, Inc. | June 27, 2025 | Approve 2025 Share Incentive Scheme | Compensation | Board | AGAINST | 1 | |
| XPeng, Inc. | June 27, 2025 | Approve Grant of RSUs to Xiaopeng He Pursuant to the 2025 Share Incentive Scheme and Related Transactions | Compensation | Board | AGAINST | 1 | |
| XPeng, Inc. | June 27, 2025 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 1 | |
| XPeng, Inc. | June 27, 2025 | Approve PricewaterhouseCoopers and PricewaterhouseCoopers Zhong Tian LLP as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 1 | |
| XPeng, Inc. | June 27, 2025 | Approve Total Number of Class A Ordinary Shares Which May be Issued in Respect of All Awards to be Granted Under the 2025 Share Incentive Scheme and Any Other Share Schemes or Plans of the Company | Compensation | Board | AGAINST | 1 | |
| XPeng, Inc. | June 27, 2025 | Authorize Board or Its Delegates to Deal with All Matters in Relation to the 2025 Share Incentive Scheme | Compensation | Board | AGAINST | 1 | |
| XPeng, Inc. | June 27, 2025 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 1 | |
| Zevia PBC | June 12, 2025 | Election of Directors: To be elected for terms expiring in 2028: Andrew Ruben | Director Elections | Board | AGAINST | 1 | |
| comScore, Inc. | June 17, 2025 | The adoption of an amendment to the Certificate of Designations (the "COD") of the Series B Convertible Preferred Stock ("Series B Preferred Stock") (1) to increase the number of authorized shares designated as Series B Preferred Stock from 100,000,000 to 104,000,000 and (ii) to clarify that shares of Series B Preferred Stock issued as payment for accrued dividends on the Series B Preferred Stock, or in lieu thereof, will count toward the $100,000,000 threshold required for the company to undertake a Mandatory Conversion (as defined in the COD) | Capital Structure | Board | AGAINST | 1 | |
| comScore, Inc. | June 17, 2025 | The approval of an amendment to the Amended and Restated 2018 Equity and Incentive Compensation Plan to increase the number of shares of the company's common stock available for grant by 2,000,000 | Compensation | Board | AGAINST | 1 | |
| comScore, Inc. | June 17, 2025 | The approval, in accordance with Nasdaq Listing Rule 5635(d), of the issuance of common stock or Series B Preferred Stock as payment for accrued dividends on the Series B Preferred Stock or in lieu thereof, if elected by the Disinterested Directors (as defined in the COD) or agreed between the Disinterested Directors and the holders of Series B Preferred Stock, as applicable | Capital Structure | Board | AGAINST | 1 | |
| eHealth, Inc. | June 18, 2025 | Approval of an amendment and restatement of the eHealth, Inc. 2024 Equity Incentive Plan to increase the maximum number of shares of common stock that may be issued thereunder by 1,500,000 shares. | Compensation | Board | AGAINST | 1 | |
| iBio, Inc. | November 21, 2024 | Election of Directors: Evert Schimmelpennink | Director Elections | Board | WITHHOLD | 1 |
← Previous Page 25 of 25
← Back to Guggenheim 2024-2025 overview
Built October 18, 2026 from SEC Form N-PX filings.